Site Content

Walt Peschel and his son who survived COVID 19 without hospitalization in record time. Walt has  had 19 heart stints and has diabetes. He was a prime candidate to expire. Treated ONLY with his drug combination.

Four patients, metabolic syndrome, 2-20 years participation.

Six patients Parkinson's disease, up to 4 years participation.

Two patients diabetic macular edema, 1 year participation.

One patient, uveitis, 4 year participation.

"...Our preliminary studies indicate that the cocktail is extremely neuroprotective in our model of transient cerebral ischemia. I'm confident, given the pharmacology of these agents and our own work with the drugs, that the cocktail will be useful as a potential treatment of several types of neurodegenerative diseases."

Dr. Tuttle is board certified in Nephrology and Internal Medicine and is published in over a dozen prestigious journals. The following from a letter from Dr. Tuttle to The Montana Neuroscience Institute and to the St. Patrick Hospital Foundation:

"I am pleased to write this letter in support of your proposal to the Montana Board of Research and Commercialization Technology for a grant to support the active research program focus on inflammatory mechanisms linked to a succession of important health concerns for the people of Montana.

"Walter Peschel, MD, has developed a compelling hypothesis regarding adverse consequences of an inappropriate inflammatory response to produce both acute and chronic illnesses. Based on a thoughtful understanding of underlying biological mechanisms, he has proposed a multi-pronged treatment strategy that appears to normalize such inflammatory responses....

...Moreover, Dr. Peschel's treatment strategy employs unique combinations of commonly used medicines, many of which are low cost and available in generic form. If proven to be effective in more definitive studies, this treatment combination could conceivably be an inexpensive, readily available approach to reduce the impact of several devastating disease conditions in Montana and beyond...." 

"...I have been tremendously impressed by Dr. Peschel's medical breadth of knowledge, his amazing ability to develop innovative and cutting edge research from clinical observations on his diabetic patients including himself. ....Based on Dr. Peschel's track record and his collaboration with experienced basic science and clinical researchers, there is no doubt in my mind that the investigational studies in his proposal will be very productive and lead to a widely used treatment using a combination of several inexpensive drugs easily combined in a single capsule."

"....one cannot argue with the clinical data and results after decades of this compassionate effort for his (Dr. Peschel's) patients who were hopelessly struggling with chronic diseases. The results are remarkable."